Barely Significant
← all excerpts

Milnacipran for the management of fibromyalgia syndrome.

J Pain Res · 2010 · PMC3004654 · PMID 21197306

1
hedged sentence
closest p
boldest claim

The sentences

While the 100 mg/day group had a responder rate that was higher than the rate in the 200 mg/day group (26.8% versus 25.9%, respectively), this difference failed to reach statistical significance in comparison to placebo, likely caused by lower statistical power due to the lower number of subjects in the 100 mg/day versus 200 mg/day group.

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.